PCN Insights, News, Videos, and More

Deutetrabenazine may provide long-term treatment benefits to patients with tardive dyskinesia (TD), according to a post hoc analysis presented in a poster at Psych Congress 2021.

The Yale University School of Medicine announced that 2 researchers from its Department of Psychiatry have been awarded a $2 million grant from the Michael J. Fox Foundation for Parkinson’s Research to conduct the first clinical trial for the...

SMI Adviser, in partnership with the NASMHPD and the NASMHPD Research Institute, has published a report on how to improve the availability, accessibility, and acceptability of mental health care in rural and remote areas.

In an Evolution of Psychotherapy keynote interview, Irv Yalom, MD, professor emeritus of psychiatry at the Stanford University School of Medicine, said helping patients find ways to work toward a regret-free life can help lessen the burden of...

After the implementation of the CMS public reporting of nursing home antipsychotic use, the proportion of residents with different forms of dementia also diagnosed with schizophrenia increased — and more so among patients who were Black...

New research shows an intervention combining CBSST-CCT improved negative symptoms and verbal learning in adults with schizophrenia.